| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.1M | +160.7% |
| Cost of Revenue | $38.4M | +1.8% |
| Gross Profit | -$25.3M | +22.6% |
| R&D Expense | $24.5M | +5.4% |
| SG&A Expense | $55.6M | -24.1% |
| Operating Income | -$105.3M | +18.4% |
| Pre-tax Income | -$124.0M | -5.8% |
| Income Tax | -$111K | — |
| Net Income | -$123.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.8M | -74.0% |
| Accounts Receivable | $4.5M | +115.0% |
| Inventory | $45.4M | +413.1% |
| Current Assets | $93.8M | -32.7% |
| Total Assets | $141.7M | -22.5% |
| Current Liabilities | $53.3M | -15.8% |
| Total Liabilities | $58.6M | -21.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$123.0M | -31.1% |
| Capital Expenditures | $18.7M | +6.8% |
| Investing Cash Flow | -$18.7M | +6.7% |
| Financing Cash Flow | $78.3M | +582.7% |
| Free Cash Flow | -$141.7M | -27.3% |
| -5.7% |
| EPS (Basic) | -$0.60 | +18.9% |
| EPS (Diluted) | -$0.60 | +18.9% |
| Stockholders' Equity |
| $83.1M |
| -23.5% |